Evidence map›Paper›PMID 35101035›Full record

ArticleCancer cell international2022

LINC00665 up-regulates SIN3A expression to modulate the progression of colorectal cancer via sponging miR-138-5p.

Shoushan Nan, Shuangxia Zhang, Rong Jin, Juelei Wang

Open access · goldAbstract read
In one paragraph

Article in Cancer cell international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shoushan Nan *Department of Gastroenterology, Tianjin Fifth Center Hospital, No. 41 Zhejiang Road, Binhai New District, Tianjin, 300450, China. shou955992558@163.com.ORCID http://orcid.org/0000-0003-0050-4121
Shuangxia Zhang *Department of Gastroenterology, Tianjin First Center Hospital, Tianjin, 300384, China.
Rong JinDepartment of Gynaecology and Obstetrics, Tianjin Fifth Center Hospital, Tianjin, 300450, China.
Juelei WangDepartment of Gastroenterology, Tianjin Fifth Center Hospital, No. 41 Zhejiang Road, Binhai New District, Tianjin, 300450, China.
Fifth Tianjin Central Hospital · CNTianjin First Center Hospital · CN

Funding

Science and Technology Project of Tianjin Binhai New Area Health Bureau No. 2013bwky031
6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) is a malignant tumor affecting people worldwide. Long noncoding RNAs (lncRNAs) is a crucial factor modulating various cancer progression, including CRC. Long intergenic non-protein coding RNA 665 (LINC00665) has been proven as an oncogene in several cancers, but its function in CRC is still unclear.

methodsQRT-PCR was performed for RNA quantification. Functional assays were designed and carried to test cell phenotype while mechanism experiments were adopted for detecting the interaction of LINC00665, microRNA-138-5p (miR-138-5p) and SIN3 transcription regulator family member A (SIN3A). In vivo experiments were conducted to test LINC00665 function on modulating CRC tumor progression.

resultsLINC00665 displayed high expression in CRC tissues and cells, and promoted tumor progression in vivo. MiR-138-5p displayed abnormally low expression in CRC, and was verified to be sponged by LINC00665. Furthermore, SIN3A, as the downstream mRNA of miR-138-5p, exerted promoting impacts on CRC cells. Rescue experiments certified that overexpressed SIN3A or silenced miR-138-5p could offset the repressed function of LINC00665 knockdown on CRC progression.

conclusionsLINC00665 could sponge miR-138-5p to up-regulate SIN3A expression, thus accelerating CRC progression.

Indexed as

Colorectal cancerLINC00665miR-138-5pSIN3A

Identifiers

PMID35101035
PMCPMC8802510
OpenAlexW4210651881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.